Welsis Corp. Files 10-Q for Period Ended December 31, 2023

TL;DR

<b>Welsis Corp. has submitted its quarterly report (10-Q) for the period ending December 31, 2023, detailing its financial performance and operational status.</b>

AI Summary

Welsis Corp. (WLSS) filed a Quarterly Report (10-Q) with the SEC on January 29, 2024. Welsis Corp. filed a Form 10-Q for the quarterly period ended December 31, 2023. The filing covers the period from October 1, 2023, to December 31, 2023. The company is incorporated in Wyoming and its principal executive offices are located in Belgrade, Serbia. Welsis Corp. is registered under the Securities Exchange Act of 1934. The filing includes financial data for the period ending December 31, 2023, and comparative periods.

Why It Matters

For investors and stakeholders tracking Welsis Corp., this filing contains several important signals. This 10-Q filing provides investors and stakeholders with an updated view of Welsis Corp.'s financial health and operational progress as of the end of the fourth quarter of 2023. The detailed financial information within the report is crucial for assessing the company's performance trends, potential risks, and future outlook in the health services sector.

Risk Assessment

Risk Level: low — Welsis Corp. shows low risk based on this filing. The filing is a standard quarterly report (10-Q) and does not contain immediate, significant financial disclosures or events that would indicate high risk.

Analyst Insight

Monitor future filings for detailed financial results and management's discussion and analysis to understand Welsis Corp.'s performance trajectory.

Key Numbers

• 2023-12-31 — Period End Date (The report is for the quarterly period ended on this date.)
• 2024-01-29 — Filing Date (The date the 10-Q was filed with the SEC.)
• 8000 — SIC Code (Primary Standard Industrial Classification Number.)

Key Players & Entities

• Welsis Corp. (company) — Filer of the 10-Q report.
• 2023-12-31 (date) — Quarterly period ended date.
• 2024-01-29 (date) — Filing date of the report.
• Wyoming (location) — State of incorporation.
• Belgrade, Serbia (location) — Principal executive offices address.
• 1934 Act (regulation) — Securities Exchange Act under which the report is filed.

FAQ

Industry Context

Welsis Corp. operates within the health services industry, as indicated by its SIC code 8000.

Regulatory Implications

The filing is made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, which governs periodic reporting requirements for public companies.

What Investors Should Do

1. Review the full 10-Q document for detailed financial statements and management's discussion and analysis.
2. Analyze comparative financial data for previous periods to identify performance trends.
3. Monitor future SEC filings for ongoing updates on Welsis Corp.'s financial condition and business operations.

Key Dates

• 2023-12-31: Quarterly Period End — The end date for the financial reporting period covered by the 10-Q.
• 2024-01-29: Filing Date — The date the Form 10-Q was officially submitted to the SEC.

Year-Over-Year Comparison

This filing is a standard 10-Q for the period ended December 31, 2023, and does not provide direct comparative data within the provided text against a previous filing.

Key Financial Figures

• $0.0001 — – $ – $ – Shares issued for cash at $0.0001 per share on August 18, 2021 2,000,000
• $0.03 — ( 56,699 ) Shares issued for cash at $0.03 per share during June – September 2022
• $200 — pany issued 2,000,000 common shares for $200 at par value $0.0001 for the purpose of
• $2,000 — ed December 31, 2023, we have generated $2,000 revenue from consulting services. Our
• $13,264 — hree months ended December 31, 2023 was $13,264. Operating expenses consist of mainly p
• $3,500 — ed December 31, 2022, we have generated $3,500 revenue from consulting services. Our
• $9,211 — hree months ended December 31, 2022 was $9,211. Operating expenses consist of mainly p
• $22,701 — ecember 31, 2023, our total assets were $22,701 consisting of Mobile Application and We
• $21,333 — Application and Website Development of $21,333 As of December 31, 2023, our total liab
• $153,939 — er 31, 2023, our total liabilities were $153,939 consisting of: Current Liabilities A
• $10,265 — flows used in operating activities was $10,265 consisting of: Operating Activities
• $23,133 — s ended December 31, 2023, we generated $23,133 consisting of: Financing Activities

Filing Documents

• welsis_i10q-123123.htm (10-Q) — 260KB
• welsis_ex3101.htm (EX-31.1) — 12KB
• welsis_ex3201.htm (EX-32.1) — 5KB
• 0001683168-24-000525.txt (&nbsp;) — 1581KB
• none-20231231.xsd (EX-101.SCH) — 14KB
• none-20231231_cal.xml (EX-101.CAL) — 23KB
• none-20231231_def.xml (EX-101.DEF) — 21KB
• none-20231231_lab.xml (EX-101.LAB) — 120KB
• none-20231231_pre.xml (EX-101.PRE) — 91KB
• welsis_i10q-123123_htm.xml (XML) — 116KB

Financial Statements (Unaudited)

Financial Statements (Unaudited) 3 Balance Sheet 3 4 5 6 Notes to the Financial Statements 7 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 12 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 14 Item 4.

Controls and Procedures

Controls and Procedures 14 PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 15 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 15 Item 3. Defaults Upon Senior Securities 15 Item 4. Mine Safety Disclosures 15 Item 5. Other Information 15 Item 6. Exhibits 16

. FINANCIAL INFORMATION

PART I . FINANCIAL INFORMATION

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) WELSIS CORP. BALANCE SHEET December 31, 2023 September 30, 2023 (Unaudited) (Audited) ASSETS Current Assets Escrow Account $ 1,368 $ 9,834 Total Current Assets 1,368 9,834 Non-Current Intangible Assets Mobile Application and Website Development 21,333 23,333 Total Non-Current Intangible Assets 21,333 23,333 Total Assets $ 22,701 $ 33,167 LIABILITIES Current Liabilities Accounts Payable $ 77,300 $ 75,500 Interest Payable 9,324 8,325 Accounts Payable - Related party 27,315 27,315 Total Current liabilities 113,939 111,140 Long term liabilities Notes Payable 40,000 40,000 Total long term liabilities 40,000 40,000 Total Liabilities 153,939 151,140 Stockholders' Equity Common stock, $ 0.0001 par value, 75,000,000 shares authorized; 2,752,667 shares issued and outstanding 276 276 Additional paid-in-capital 22,504 22,504 Accumulated deficit ( 154,017 ) ( 140,753 ) Total Stockholders' Equity ( 131,237 ) ( 117,973 ) Total Liabilities and Stockholders' Equity $ 22,701 $ 33,167 The accompanying notes are an integral part of these financial statements. 3 WELSIS CORP. (Unaudited) Three months ended December 31, 2023 Three months ended December 31, 2022 Revenue (Consulting) $ 2,000 $ 3,500 General and administrative expenses 15,264 12,711 Total operating expenses ( 15,264 ) ( 12,711 ) Net income (loss) from operations ( 13,264 ) ( 9,211 ) Provisions from Income Taxes – – NET INCOME (LOSS) $ ( 13,264 ) $ ( 9,211 ) Net Loss per common share: Basic $ ( 0.00 ) $ ( 0.00 ) Net Loss per common share: Diluted $ ( 0.00 ) $ ( 0.00 ) Weighted Average Number of Common Shares Outstanding: Basic 2,752,667 2,752,667 Weighted Average Number of Common Shares Outstanding: Diluted 2,752,667 2,752,667 The accompanying notes are an integral part of these financial statements.

Management's Discussion and Analysis of Financial

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

FORWARD LOOKING STATEMENTS

FORWARD LOOKING STATEMENTS historical or current facts are "forward-looking statements" made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 (the "Act") and Section 21E of the Securities Exchange Act of 1934. These statements often can be identified by the use of terms such as "August," "will," "expect," "believe," "anticipate," "estimate," "approximate" or "continue," or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management's best judgment as to what June occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events. Employees and Employment Agreements At present, we have no employees other than our officer and director. We presently do not have pension, health, annuity, insurance, stock options, profit sharing or similar benefit plans; however, we August adopt such plans in the future. There are presently no personal benefits available to any officers, directors or employees. Results of Operation Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk No report required.

Controls and Procedures

Item 4. Controls and Procedures Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer's management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2023. Based on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms. Such officer also confirmed that there was no change in our internal

View Full Filing

View this 10-Q filing on SEC EDGAR